CoChat
Sign Up
Cited by 23Pharmaceutical Quality and CounterfeitingPharmaceutical Economics and PolicyHealthcare Regulation

How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria

Amadi, Chioma, Tsui, Emma K.·2019·Research in Social and Administrative Pharmacy
DOI 10.1016/j.sapharm.2018.11.011
Open this paper in CoChat — free account

Abstract

Background Limited access to essential medicines for maternal and child health is a preventable cause of pregnancy-related deaths. This remains a predominant challenge in Nigeria, where sub-standard and falsified medications have historically been associated with maternal mortality. An in-depth understanding of perceptions surrounding quality assurance of essential medicines is pertinent for developing effective and sustainable interventions. Objective To examine stakeholder perspectives on quality control of essential medicines for maternal and child health, while characterizing pharmaceutical distribution of medicines in Nigeria. Methods Key informant interviews were conducted with a purposive sample of 26 participants between January and June 2018. Eligible participants included: pharmacists, pharmaceutical sales representatives (pharm reps), supply chain employees of pharmaceutical industries and regulatory agency personnel, working in the public or private health sector in either of the four states: Lagos, Enugu, Imo or Port-Harcourt. A 6-item survey was administered to collect demographic information on the participants. This was followed by 15 semi-structured questions to gather qualitative data on the subject matter. Results Verifying vendor credibility and use of identifiable regulatory markers were the most common methods adopted by pharmacists and pharm reps with the intent to control quality of medicines. Key challenges in assuring quality included: inefficiency o…

Integrity signals

Registry

Crossref · 10.1016/j.sapharm.2018.11.011

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Challenges associated with medicine supply chain in Nigeria have been identified in the literature, ranging from poor infrastructure, weak policy or regulatory implementation, and quality compromised by substandard or counterfeit medicines.

    “Challenges associated with medicine supply chain, in Nigeria, have been identified in the literature ranging from poor infrastructure, weak policy or regulatory implementation and quality compromised by substandard or counterfeit medicines [4].”

    From Medicines and vaccines supply chains challenges in Nigeria: a scoping review (2022) · cites this paper as [4]

  • The review identified policy and standard operating procedure challenges in Nigeria's medicine supply chain, including inadequate implementation of medicine distribution policies, sub-optimal implementation of policies, and non-adherence to policies.

    “Inadequate implementation of medicine distribution policies, sub-optimal implementation of policies, non-adherence to policies”

    From Medicines and vaccines supply chains challenges in Nigeria: a scoping review (2022) · cites this paper as [4]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Amadi, C., & Tsui, E. K.
Affiliations
City University of New York (US)
Corresponding author
Amadi, Chioma
ORCID
Venue
Research in Social and Administrative Pharmacy
Publisher
Elsevier BV
Published
2019-11
Volume
15
Issue
11
Pages
1344-1357
ISSN
1551-7411 (ISSN-L)
DOI
10.1016/j.sapharm.2018.11.011
OpenAlex
W2902283514
Cited by
23
References
19
Citations by year
2026: 3 · 2025: 4 · 2024: 8 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 2
FWCI
1.20
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Research in Social and Administrative Pharmacy (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • United States Agency for International Development
  • City University of New York
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Health Professions › Health Information Management › Healthcare Regulation
Keywords
essential medicines, pharmaceutical supply chain, substandard and falsified medicines, maternal and child health, stakeholder perspectives, regulatory agencies, NAFDAC, pharmacists, pharmaceutical sales representatives, policy implementation, public-private partnerships, Nigeria
MeSH terms
Child Health, Maternal Health, Stakeholder Participation, Drug Industry, Female, Humans, Nigeria, Perception, Pharmacies, Pharmacists, Quality Control, Drugs, Essential

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review